从公立和私立医院的功能性发作患者的药物使用
Gabriele Vilyte1, James Butler2, Victoria Ives-Deliperi3
1Department of Psychology, Faculty of Arts and Social Sciences, Stellenbosch University, Stellenbosch, South Africa.
Seizure
|February 28, 2024
概括
来自开普敦公共医院的功能性发作 (FS) 患者在呈现时不太可能接受抗发作药物 (ASM) 和精神病药物,但更有可能以ASM出院. 这表明FS护理质量存在差异.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 功能性发作 (FS),也称为心理非发作 (PNES),是一种神经疾病,对社会经济差异的研究有限.
- 在FS患者的药物使用模式可能反映了社会经济群体之间的医疗保健质量和医疗保健获取差异.
研究的目的:
- 为了比较使用抗发作药物 (ASM),精神病治疗药物和其他药物,在公共与私人监测单位 (EMU) 治疗的FS患者.
- 根据社会经济背景,调查FS患者药理护理质量的潜在差异.
主要方法:
- 一项涉及视频脑电图 (视频EEG) 的回顾性病例控制研究证实了没有并发性的FS患者.
- 关于药物史 (ASM,精神病,心血管) 的数据从公立和私立医院的数字患者记录中收集.
主要成果:
- 来自公立医院的患者 (n=67) 与私立医院 (n=305) 相比,在呈现时服用ASM或精神病药物的几率较低.
- 公共医院的病人有更高的可能性被放弃ASMs和曾经服用心血管药物.
- 增加使用呈现ASM和精神病药物降低了从公立医院出院的几率,而增加出院ASM和心血管药物增加了这些几率.
结论:
- 在开普敦的公共和私人医疗机构之间,FS患者的药理管理存在显著差异.
- 药物治疗方法的这些差异表明,对来自不同社会经济背景的FS患者提供的护理质量存在潜在的不平等.
更多相关视频
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
296
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
296
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
399
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
399
01:24Arteries of the Lower Limbs
189
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
189
01:08Antiepileptic Drugs: Sodium Channel Blockers
551
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
551
01:20Antiepileptic Drugs: Potassium Channel Activators
183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
183
01:14Antiepileptic Drugs: Glutamate Antagonists
345
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
345